New
Scientist II
Spectraforce Technologies | |
United States, Connecticut, Ridgefield | |
Apr 02, 2026 | |
|
Position Title: Scientist II
Work Location: Connecticut, Ridgefield, 06877 Assignment Duration: 12+ Months (Potential Extension) Arrangement: Onsite Key Responsibilities: Execute tissue processing to prepare high-quality samples for analysis, ensuring consistency and adherence to established protocols. Conduct tissue embedding using paraffin and frozen section techniques to enable accurate sectioning and downstream applications. Perform tissue staining, including immunohistochemistry (IHC), immunofluorescence (IF), and histological staining, to support imaging and research goals. Troubleshoot and optimize protocols to ensure reproducible, high-quality results. Collaborate with researchers to design experiments, analyze data, and interpret findings. Maintain detailed records of procedures, results, and inventory in compliance with laboratory standards. Qualification & Experience: Experience: 3-5 years of hands-on experience in tissue processing, tissue staining, and tissue embedding in a research or clinical laboratory setting. Technical Skills: Proficiency in histological techniques, including paraffin and cryosectioning. Expertise in IHC, IF, and other histological staining methods. Ability to troubleshoot and optimize tissue preparation protocols. Analytical Skills: Strong attention to detail and ability to analyze and interpret experimental data. Organizational Skills: Excellent time-management and multitasking abilities to handle multiple projects efficiently. Communication Skills: Clear written and verbal communication for collaborating with researchers and documenting procedures. Teamwork: Ability to work both independently and collaboratively in a team-oriented research environment. Compliance: Familiarity with laboratory safety protocols and quality control standards. Education: Master's degree in biology, biomedical sciences, or a related field (bachelor's degree with significant relevant experience may be considered). | |
Apr 02, 2026